Photo from Envato
Advancements in newer therapies are expected to drive its expansion.
A rise in incident cases, expanded use of existing treatments, and increased research and development activities are driving the multiple myeloma market to witness substantial growth, said DelveInsight Business Research, LLP.
Advancements in newer therapies such as CAR-T cell therapies and bispecific antibodies are also expected to drive the sector’s expansion.
“Whilst current CAR-T treatments rely on a patient’s own T cells (autologous), research is underway to develop allogeneic CAR-T cells sourced from healthy donors,” the report said.
In addition, the treatment landscape is shifting with the increasing adoption of monoclonal antibodies for newly diagnosed patients.
Join
Healthcare Asia Magazine
community
Since you’re here…
…there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!
